Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.

MLA

Aupetit, J. F., et al. “Ischaemia-Induced Loss or Reversal of the Effects of the Class I Antiarrhythmic Drugs on Vulnerability to Fibrillation.” British Journal of Pharmacology, vol. 120, no. 3, Feb. 1997, pp. 523–29. EBSCOhost, https://doi.org/10.1038/sj.bjp.0700926.

APA

Aupetit, J. F., Loufoua-Moundanga, J., Faucon, G., & Timour, Q. (1997). Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation. British Journal of Pharmacology, 120(3), 523–529. https://doi.org/10.1038/sj.bjp.0700926

Chicago

Aupetit, J F, J Loufoua-Moundanga, G Faucon, and Q Timour. 1997. “Ischaemia-Induced Loss or Reversal of the Effects of the Class I Antiarrhythmic Drugs on Vulnerability to Fibrillation.” British Journal of Pharmacology 120 (3): 523–29. doi:10.1038/sj.bjp.0700926.